Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance-Reference-Cited by-同舟云学术

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Published:2015-05 Issue:1 Volume:361 Page:112-120
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Miklos W.,Pelivan K.,Kowol C.R.,Pirker C.,Dornetshuber-Fleiss R.,Spitzwieser M.,Englinger B.,van Schoonhoven S.,Cichna-Markl M.,Koellensperger G.,Keppler B.K.,Berger W.,Heffeter P.

Funder

Austrian Science Fund

COST

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond;Yu;Clin. Cancer Res,2006

2. A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

3. Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia;Giles;Leuk. Res,2003

4. A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas;Attia;Invest. New Drugs,2008

5. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells;Ma;Invest. New Drugs,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance;Cancers;2022-09-14

2. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance;Drug Resistance Updates;2021-09

3. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux;Journal of Medicinal Chemistry;2020-11-16

4. Aberrant DNA Methylation of ABC Transporters in Cancer;Cells;2020-10-13

5. Syntheses, quantum mechanical modeling, biomolecular interaction and in vitro anticancer – Tubulin activity of thiosemicarbazones;Bioorganic Chemistry;2020-09